Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haploidentical Donor Hematopoietic Stem Cell Transplantation

NCT02660281 is registered in ClinicalTrials.gov with University of Rochester as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02660281 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haploidentical Donor Hematopoietic Stem Cell Transplantation
Lead sponsor
University of Rochester
Phase
Phase 1
Overall status
Completed
Start date
October 31, 2015
Completion date
January 7, 2021
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hematological disease, immune deficiencies, lymphoma, multiple myeloma, myelofibrosis, solid tumors